| 201 |
Synthesis, anti-inflammatory and molecular docking of some new 1,2,4-triazolobenzimidazol-3-yl acetone thiosemicarbazone cyclized derivatives as PLA-2 inhibitors |
2015 |
| 202 |
Design and Synthesis of New (SecinH3) Derivatives as Potential Cytohesin Inhibitors |
2014 |
| 203 |
Design and synthesis of new pyrido[2,3-d]pyrimidine-1,4-dione derivatives as anti-inflammatory agents |
2014 |
| 204 |
Design and Synthesis of Some New Purine-dione Derivatives of Potential Anti- inflammatory Activity |
2014 |
| 205 |
Discovery of New HER2/EGFR Dual Kinase Inhibitors Based on the Anilinoquinazoline Scaffold as Potential Anti-Cancer Agents |
2014 |
| 206 |
Expanding the scaffold for bacterial RNA polymerase inhibitors: Design, synthesis and structure activity relationships of ureido-heterocyclic-carboxylic acids |
2014 |
| 207 |
Facile Synthesis, Molecular Docking, and Biological Screening of 1,3-Disubstituted Urea Derivatives |
2014 |
| 208 |
In Silico Studies of Quinoxaline-2-Carboxamide 1,4-di-N-Oxide Derivatives as Antimycobacterial Agents |
2014 |
| 209 |
Surface plasmon resonance – more than a screening technology: insights in the binding mode of σ70:core RNAP inhibitors |
2014 |
| 210 |
Synthesis and Characterization of bis-3,5-Disubstituted Thiadiazine-2-thione Derivatives as Anticancer Agents |
2014 |
